News
Luminopia's amblyopia treatment now includes patients aged 8 to 12, expanding its previous FDA approval for ages 4 to 7. The ...
Treatment with cyclosporine A 0.1% can reduce ocular surface temperature in patients with dry eye disease and meibomian gland dysfunction.
Preservative free cyclosporine is safe and effective for treating mild to moderate dry eye disease, a study shows.
Bausch & Lomb Reports Weak Start to 2025 as enVista Recall, Tariffs, and Drug Pricing Cause Concerns
Bausch & Lomb is one of the largest vision care companies in the US. Bausch spun off from its former parent company, Bausch Health, in 2022 and it now operates in three segments: vision care, surgical ...
Bausch + Lomb (NYSE:BLCO) stock drops as the company lowers its growth outlook after lower than expected Q1 2025 financials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results